mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-07 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |